NexGel Inc (NXGL) AI Stock Analysis

• Market Cap: $23.44M
• Dividend Yield: N/A
• Average Volume (3M): 50.95K
• Price to Earnings (P/E): ―
• Beta (1Y): 0.82
• Revenue Growth: 73.38%
• EPS Growth: 34.87%
• Country: US
• Employees: 19
• Sector: Healthcare
• Sector Strength: 45
• Industry: Medical - Instruments & Supplies
• EPS (TTM): -0.08
• Shares Outstanding: 8,067,580
• 10 Day Avg. Volume: 60,354
• 30 Day Avg. Volume: 50,949
• PEG Ratio: 0.83
• Price to Book (P/B): 5.05
• Price to Sales (P/S): 3.34
• P/FCF Ratio: -6.74
• Enterprise Value/Market Cap: 0.94
• Enterprise Value/Revenue: 1.89
• Enterprise Value/Gross Profit: 4.94
• Enterprise Value/Ebitda: -9.87
• 1Y Price Target: $6.00
• Price Target Upside: 233.33% Upside
• Rating Consensus: Moderate Buy
• Number of Analyst Covering: 1
• EPS Forecast (FY): N/A
• Revenue Forecast (FY): N/A

• Rating: 41 Neutral
• Price Target: $1.50 ▼(-16.67% Downside)

NexGel Inc's overall stock score is primarily impacted by its financial performance and valuation. Persistent net losses and negative cash flows present significant risks, while the bearish technical indicators further weigh on the stock. The absence of a dividend yield and negative P/E ratio highlight valuation concerns. Despite some positive guidance from the earnings call, the challenges in profitability and market momentum are the most significant factors affecting the score.

Positive Factors

Revenue Growth

Strong revenue growth indicates expanding market reach and successful product adoption, which is crucial for long-term business sustainability.

Strategic Partnerships

Strategic partnerships enhance market presence and provide steady revenue streams, supporting long-term growth and competitive positioning.

Product Expansion

Product expansion into new segments diversifies revenue sources and strengthens market position, fostering sustainable growth.

Negative Factors

Persistent Net Losses

Ongoing net losses hinder profitability and financial stability, posing risks to long-term viability and investor confidence.

Negative Cash Flows

Negative cash flows indicate operational inefficiencies and can limit the company's ability to invest in growth opportunities.

Logistical Delays

Logistical delays can disrupt supply chains and sales, impacting revenue and operational efficiency over the medium term.

NexGel Inc Business Overview & Revenue Model

Company Description

NEXGEL, Inc. manufactures high water content, electron beam cross-linked, and aqueous polymer hydrogels and gels. Its products are used for wound care, medical diagnostics, transdermal drug delivery, and cosmetics. The company was formerly known as AquaMed Technologies, Inc. and changed its name to NEXGEL, Inc. in November 2019. NEXGEL, Inc. was founded in 1997 and is based in Langhorne, Pennsylvania.

How the Company Makes Money

NexGel generates revenue through the sale of its proprietary hydrogel products to healthcare providers, distributors, and retail outlets. The company has established key partnerships with healthcare institutions and manufacturers that facilitate the distribution of its products, enhancing its market reach. Additionally, NexGel may also engage in contract manufacturing services, creating customized hydrogel solutions for clients, which adds another layer to its revenue model. The successful commercialization of new products and the expansion into emerging markets further contribute to the company's earnings.

NexGel Inc Financial Statement Overview

Summary

NexGel Inc shows strong revenue growth, reflecting potential in its core business operations. However, persistent net losses and negative cash flows indicate challenges in achieving profitability and financial stability. The balance sheet remains stable with a reasonable equity position, but the company must address profitability issues to improve its financial health. Continuous negative cash flow and net income are key risks that need to be managed.

Income Statement

NexGel Inc has experienced significant revenue growth over the years, with a notable increase from 2023 to 2024. However, the company continues to report negative net income, leading to a negative net profit margin. The gross profit margin has improved, but operating losses remain a concern, reflected in negative EBIT and EBITDA margins. The improvement in revenue is overshadowed by persistent losses, impacting overall profitability.

Balance Sheet

The company maintains a moderate debt-to-equity ratio with an increasing stockholders' equity base, indicating a stable equity position. However, the return on equity remains negative due to ongoing net losses, which is concerning. The equity ratio is healthy, suggesting that the company is not overly reliant on debt financing. Despite these positive aspects, the inability to generate net income affects overall stability.

Cash Flow

NexGel Inc's cash flow statements show negative operating and free cash flows, indicating operational challenges. Despite this, the company has managed to secure financing, which has supported cash flow needs. However, the inability to generate positive free cash flow to net income ratio highlights the ongoing struggles in achieving cash flow profitability.

Breakdown	TTM	Dec 2024	Dec 2023	Dec 2022	Dec 2021	Dec 2020
Income Statement
Total Revenue	11.66M	8.69M	4.09M	2.05M	1.55M	674.00K
Gross Profit	4.47M	2.75M	374.00K	256.00K	8.00K	-291.00K
EBITDA	-2.23M	-2.90M	-2.73M	-3.11M	-2.17M	-2.20M
Net Income	-2.88M	-3.28M	-3.16M	-4.75M	-4.31M	-2.26M
Balance Sheet
Total Assets	11.62M	10.98M	9.96M	10.36M	16.98M	2.26M
Cash, Cash Equivalents and Short-Term Investments	938.00K	1.81M	2.70M	6.61M	13.35M	32.00K
Total Debt	3.09M	2.83M	2.80M	2.08M	4.26M	1.28M
Total Liabilities	6.04M	4.90M	4.79M	2.72M	4.90M	2.19M
Stockholders Equity	5.19M	5.75M	4.70M	7.64M	12.09M	71.00K
Cash Flow
Free Cash Flow	-2.55M	-4.31M	-3.93M	-3.09M	-3.02M	-2.11M
Operating Cash Flow	-2.45M	-3.87M	-3.24M	-2.99M	-2.75M	-1.80M
Investing Cash Flow	-91.00K	-775.00K	4.46M	-5.59M	-269.00K	-312.00K
Financing Cash Flow	3.34M	3.75M	379.00K	-3.66M	16.34M	1.88M

NexGel Inc Technical Analysis

• Technical Analysis Sentiment: Negative
• Last Price: 1.80
• 50DMA: Negative
• 100DMA: Negative
• 200DMA: Negative
• MACD: Positive
• RSI: Neutral
• STOCH: Neutral

Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For NXGL, the sentiment is Negative. The current price of 1.8 is below the 20-day moving average (MA) of 2.02, below the 50-day MA of 2.33, and below the 200-day MA of 2.53, indicating a bearish trend. The MACD of -0.20 indicates Positive momentum. The RSI at 37.65 is Neutral, neither overbought nor oversold. The STOCH value of 54.97 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Negative sentiment for NXGL.

NexGel Inc Peers Comparison

Name	Overall Rating	Market Cap	P/E Ratio	ROE	Dividend Yield	Revenue Growth	EPS Growth
Sector *	51 Neutral	$7.86B	-0.30	-43.30%	2.27%	22.53%	-2.21%
POCI	51 Neutral	$36.18M	-5.52	-57.98%	―	13.67%	-37.01%
FEMY	48 Neutral	$53.80M	―	-376.23%	―	63.53%	12.49%
RVP	48 Neutral	$25.18M	-2.81	-8.05%	―	-0.95%	58.17%
NXGL	41 Neutral	$23.44M	-5.47	-58.34%	―	73.38%	34.87%
MLSS	41 Neutral	$29.73M	-4.35	-136.47%	―	0.59%	-39.76%
SMTI	41 Neutral	$186.93M	―	-27.19%	―	30.55%	-340.19%

NexGel Inc Corporate Events

Nexgel’s Earnings Call: Strategic Moves Amidst Challenges

In the latest earnings call, Nexgel, Inc. presented a balanced view of its recent performance, highlighting notable improvements in gross profit margins and strategic partnerships. The company also discussed product expansions, although it faced challenges with flat revenue growth and logistical delays.

NexGel Inc Reports Q3 2025 Financial Results

On November 11, 2025, NEXGEL, Inc. reported its third quarter 2025 financial results, showing a slight decrease in net revenue to $2.93 million compared to the previous year. Despite a flat revenue, the company improved its gross profit margin to 42.4% and narrowed its adjusted EBITDA loss, driven by strong performance in contract manufacturing and consumer branded products. The company continues to expand its reach with new product launches and strategic partnerships, reflecting confidence in its advanced hydrogel technology.

The most recent analyst rating on (NXGL) stock is a Hold with a $2.50 price target. To see the full list of analyst forecasts on NexGel Inc stock, see the NXGL Stock Forecast page.

NEXGEL, Inc. Reports Steady Q3 2025 Performance

NEXGEL, Inc., based in Langhorne, Pennsylvania, is a prominent provider of healthcare, beauty, and over-the-counter products, specializing in ultra-gentle, high-water-content hydrogel products for both healthcare and consumer applications. The company has been a leader in developing electron-beam, cross-linked hydrogels for over two decades.

NEXGEL’s Earnings Call: Growth Amid Challenges

NEXGEL, Inc. recently held its earnings call, revealing a balanced sentiment that highlighted both significant achievements and ongoing challenges. The company showcased strong revenue growth and expanded partnerships, underscoring successful product launches and strategic agreements. However, the call also pointed to ongoing losses, delays in key partnerships, and underutilized capacity as areas needing improvement.

NEXGEL, Inc. Reports Strong Q2 2025 Results

NEXGEL, Inc., based in Langhorne, Pennsylvania, is a prominent provider of healthcare, beauty, and over-the-counter products, specializing in ultra-gentle, high-water-content hydrogels for consumer and healthcare applications. The company has been in the business of developing and manufacturing these hydrogels for over two decades.